Clinical Trial Update: PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetic-directed dosing of IV busulfan as conditioning for autologous stem cell transplantation in lymphoma patients has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-31